Remdesivir to be used in patients with moderate to severe COVID-19: Health ministry

The Tocilizumab drug may be considered for use in the presence of severe disease (preferably within 24 to 48 hours of onset of severe disease/ICU admission), according to the guidelines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3Hb6lSd
via IFTTT